Aslan Fred Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$263,223.30

Insider Activity of Aslan Fred

According to the SEC Form 4 filings, Aslan Fred, being in a position of

  1. Chief Executive Officer at Artiva Biotherapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 269332 shares for $2.08M,
    over all time since 2025-08-15, has bought 0 shares, and sold 320332 shares for $2.3M.

Biography of Aslan Fred

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,081,7158100

Comparison of Insiders on Amount of Buys and Sells

2026-11-02SaleArtiva Biotherapeutics, Inc.
ARTV
Chief Executive Officer
62,178
0.1574%
$4.18$259,972+0.45%
2026-10-06SaleArtiva Biotherapeutics, Inc.
ARTV
Chief Executive Officer
23,463
0.0475%
$7.20$168,880-16.02%
2026-10-05SaleArtiva Biotherapeutics, Inc.
ARTV
Chief Executive Officer
61,696
0.1501%
$6.84$421,828-13.74%
2026-09-08SaleArtiva Biotherapeutics, Inc.
ARTV
Chief Executive Officer
23,429
0.0596%
$10.92$255,746-36.72%
2026-09-03SaleArtiva Biotherapeutics, Inc.
ARTV
Chief Executive Officer
61,888
0.1269%
$11.16$690,392-37.42%
2026-05-19SaleArtiva Biotherapeutics, Inc.
ARTV
Chief Executive Officer
27,116
0.1072%
$9.01$244,253+7.19%
2025-12-15SaleArtiva Biotherapeutics, Inc.
ARTV
President and CEO
3,187
0.0175%
$6.00$19,122+15.4%
2025-11-17SaleArtiva Biotherapeutics, Inc.
ARTV
President and CEO
6,375
0.0197%
$3.38$21,522+98.58%
2025-10-17SaleArtiva Biotherapeutics, Inc.
ARTV
President and CEO
25,500
0.1402%
$6.00$153,000+13.48%
2025-08-15SaleArtiva Biotherapeutics, Inc.
ARTV
President and CEO
25,500
0.0638%
$2.73$69,579+79.27%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.